A systematic review and meta-analysis on the efficacy and safety of Mirabegron 50 mg and 100 mg vs. Tolterodine and Placebo for Overactive Bladder/Storage LUTS.

Sebastianelli A1, Russo G I2, Cimino S2, Salvi M1, Spatafora P1, Tasso G1, Carini M1, Serni S1, Moncada I3, Gravas S4, Giuliano F5, Gacci M1

Research Type

Clinical

Abstract Category

Pharmacology

Abstract 315
Female Pelvic Floor 3
Scientific Podium Short Oral Session 18
Wednesday 13th September 2017
17:37 - 17:45
Spadolini F
Incontinence Overactive Bladder Urgency/Frequency Pharmacology
1. Department of Urology, Careggi Hospital, University of Florence (Italy), 2. Department of Urology, Policlinico Hospital, University of Catania, Catania, Italy, 3. Department of Urology, Hospital La Zarzuela, Madrid, Spain, 4. Department of Urology, University Hospital of Larissa, Larissa, Greece, 5. AP-HP, Neuro-Uro-Andrology, Versailles Saint Quentin en Yvelines University, Versailles, France
Presenter
A

Arcangelo Sebastianelli
Links

Abstract

18/04/2024 03:23:05